Obaid S. Shaikh, MD has received a grant from Mallinckrodt Pharmaceuticals to study “Predictive Modeling of Acute Kidney Injury-Hepatorenal Syndrom (AKI_HRS) Among U.S. Veterans with Cirrhosis”.